Last edition
News about "Syracuse Bio Campus "
Rakuten Medical and LOTTE Biologics Sign Manufacturing Deal for Global Oncology Programme
Rakuten Medical has entered into a manufacturing agreement with LOTTE Biologics under which LOTTE Biologics will provide advanced manufacturing services for monoclonal antibody intermediates and their conjugates, supporting Rakuten Medical’s global clinical development programmes and future commercialisation in oncology.
Syracuse Bio Campus | 19/01/2026 | By News Bureau | 168
LOTTE BIOLOGICS Enters Contract Manufacturing Partnership with US Biopharma
South Korea’s LOTTE BIOLOGICS has signed a late-stage to commercial contract manufacturing agreement with a US-based global biopharmaceutical company.
Syracuse Bio Campus | 02/09/2025 | By Dineshwori | 438
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy